Stanley Druckenmiller acquired 1.37 Million Insmed shares worth $95.5 Million. That's 2.93% of their equity portfolio (9th largest holding). The first Insmed trade was made in Q2 2020. Since then Stanley Druckenmiller bought shares three more times and sold shares on one occasions. The investor's estimated purchase price is $101 Million, resulting in a loss of 5.7%.